As a crucial transcriptional regulator in several genetic disorders, SHOX2 has been demonstrated to be an excellent biomarker in the diagnosis and evaluation of many types of cancers, including lung cancer [22, 23]. This evidence concerns the gene SHOX2 and lung carcinoma.